CVS Health Posts Upbeat Earnings, Johnson Controls Mixed Results
- August 02nd, 2023
- 533 views
CVS Health Corporation (NYSE: CVS) announced second quarter 2023 adjusted earnings per share (EPS) of $2.21 and recorded revenues of $88.92 billion, surpassing the consensus EPS estimate of $2.11 on revenues of $86.45 billion.
The company confirmed its full-year 2023 adjusted EPS guidance range of $8.50 to $8.70, aligning closely with analysts' expectations of $8.59.
In pre-market, $CVS was trading at $72.00, down $1.51 (+2.04%).
In a separate development, Johnson Controls International plc (NYSE: JCI) reported third-quarter fiscal 2023 adjusted EPS of $1.03, matching analysts' forecasts. However, quarterly sales were slightly lower than expected at $7.13 billion, compared to the consensus estimate of $7.19 billion in revenue.
For the upcoming quarter, Johnson Controls anticipates Q4 adjusted EPS of $1.10, slightly below the consensus estimate of $1.13 for the period.
$JCI was trading at $65.50 in pre-market, down $4.53 (-6.47%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026
Member Login